intrODUCtiOn
Improving health care quality and reduc ing costs are attractive selling points for dis ease management (DM) programs. DM is widely used by insurers and employers, with revenues approaching $2 billion a year (Mattke, Seid, and Ma, 2007) . The appeal of DM has spread beyond the pri vate sector and is increasingly being con sidered, if not adopted, by public payers. The growing chronic disease burden, expanding emphasis on the importance of lifestyle related conditions such as obesity, and escalating heath care costs present challenges that DM purports to address.
There are a wide array of DM programs and specific intervention services, some integrated into care delivery settings and others primarily telephonic. Some DM pro grams' focus is limited to disease specific support. Others take a broader, holistic, care management approach. This has enhanced appeal when managing populations with multiple comorbidities. A more recent focus for the industry is pop ulation health, extending the diseasespe cific and multiple conditions approaches to incorporate wellness management of entire populations, even those without chronic conditions.
There is no single definition of DM's in terventions. Interventions are not just program specific, but person specific and also often vary with each contact. Pro grams may seek to improve adherence to evidence based prevention and treatment guidelines, working with providers and/ or with patients to improve care. Other general strategies in DM include patient education aimed at improving self care and adherence to treatment plans, and to communicate with health care provid ers. Some programs include additional supports such as coordinating or provid ing trans porta tion, medication, or social support services.
Similarly, target populations can vary dramatically. Questions remain as to what criteria identify the optimal population to benefit from DM. Is it the highest cost group, a specific set of diagnoses, a particu lar utilization pattern, or some combination of these factors? Are there other subpopu lations where the benefit is minimal or nonexistent that should be excluded? DM providers working with Medicare popula tions have remarked on the challenges of multiple comorbidities, especially cogni tive impairment, and general frailty of the population. That care is delivered by many different providers for conditions that are often longstanding is often in contrast to younger, healthier populations. Overlaying this are the added complexities of other social service needs, low literacy levels, and financial issues.
The structure of the public sector pro grams often differs as well. Issues such as the timeliness of claims or other utili zation data and the inability for realtime notification of hospital admission may require altering the DM approach. The monthly management fees paid in the Medicare demonstrations reported in 
in tHiS iSSUe
This issue of the Review includes five articles that focus on management of pop ulations with chronic conditions. The first three articles present interim results from Medicare's most recent DM efforts. All address feeforservice populations, one specifically a population dually eligible for Medicare and Medicaid. The remain ing two articles report strategies used for iden tifying atrisk patients. These include defining the target population for a Statesponsored chronic care manage ment pro gram and identifying potentially prevent able hospital readmissions in a statewide all payer context.
evaluation of DM in Medicare
The evaluations of Medicare's DM and chronic care improvement programs are presented in chronological order of their start date. This also corresponds to the length of experience included in the evalu ations to date. Brown, Peikes, Chen, and Schore's findings from the Medicare coor dinated care demonstration cover 2 years of a 4year program encompassing 15 sites. The second article, by Esposito, Brown, Chen, Schore, and Shapiro reports on the first 18 months' experience DM demon stration for dually eligible beneficiaries. Finally, Cromwell, McCall, and Burton present 6month results on the Medicare Health Support pilot program.
In each of these programs, the partici pating organizations developed their ap proach and intensity of the intervention, generally based on their previous DM experience. The eligibility criteria and tar get conditions vary; diabetes, heart failure, and coronary artery disease predominate. Although all programs were intended to be budget neutral (or better), two of the three demonstrations programs were at risk financially, required to repay fees to CMS if savings targets were not met. All of the evaluations address the cost of the intervention and not just the gross savings in Medicare claims costs. Each of these demonstrations has a randomized design and follows an intenttotreat model.
Even though results are still preliminary, none of the demonstrations have displayed the outcomes or cost savings expected even at this early stage. The absence of large scale impacts challenge these evalu ation teams to shift their emphasis from quantifying the many successes to detect ing where positive impacts, beyond chance findings, have occurred.
identification of at-risk Populations
The article by Weir, Aweh, and Clark tackles the challenge of how to select the target population for Vermont's chronic care management services program. Rec ognizing that the State's population is not large enough to develop their own model to identify the relevant subset of the eligi ble population with chronic conditions, the authors sought to empirically test three externally developed predictive models to determine which was best suited to the State's needs and underlying population.
Goldfield, McCullough, Hughes, Tang, Eastman, Rawlins, and Averill report on an approach to analyzing statewide hos pital discharge data, identifying readmis sions, and classifying them as potentially preventable (PPR) or not. Characteristics of index hospitalizations most likely to generate PPRs are described as are the hospital level rates of PPR. These findings highlight potential areas for targeting qual ity improvement efforts, whether they are patientlevel efforts such as DM, or institu tionallevel strategies targeting process or payment reform.
COnClUSiOn
The debate on the utility and cost effec tiveness of DM will not have a "yes or no" answer. The articles in this issue add to the evidence that purchasers and policy makers should maintain skepticism about the potential benefits of DM and focus on the performance of specific interven tions. Consideration should be given to the rigor of the evidence and to the details on the relevance of the findings to other populations and settings. Meanwhile, as CMS continues to evaluate the ongoing or recently completed Medicare DM pro grams, other work continues to enhance strategies to refine case selection for future interventions strategies. 
